Interview: Endang W. Hoyaranda, President Director, Prodia Group, Indonesia
04.12.2013
Related Interviews
Interview: Evie Yulin – Country Director, Merck Biopharma Indonesia
Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging countries and how the company engages in innovation beyond products. Since 2012, Merck has been…
Interview: Haris Izmee – Director, GE Healthcare Indonesia
Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving access, affordability and quality and highlights the company’s significant investments in internal capabilities and…
Interview: Marlia Hayati Goestam – President Director & Joey Romana…
Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the…
Pfizer Buys Array: A Smart Move?
Pfizer, in an attempt to bolster its oncology portfolio, is set to acquire Array Biopharma for USD 10.6 billion in the second half of 2019. The deal will give Pfizer…
Is growth in the Taiwanese biotech sector a bubble that is about to burst?
In Taiwan, biotech is finally booming, and more and more of the companies benefitting from this boom are listing on the Gre Tai Securities Market (GTSM), built with small to…
Taiwan: Preparing for takeoff
The past three years have been some of the most eventful in memory for Taiwan’s life sciences industry. At this year’s Bio Taiwan exhibition, the annual conference that invites…
Latest Report
